Checkpoint proteins in patients with precancer and cervical cancer
Authors:
Preprint
Abstract
The efficiency of immuno-oncological drugs in treatment cervical cancer is not high. The research of new immunological targets in cervical cancer is actual. The aim was to study the local level of checkpoint proteins of immune cycle in patients with cervical cancer of different stages (sCD25, 4-1BB, B7.2, TGF-b1, CTLA-4, PD-L1, PD-1, Tim-3, LAG-3, Galectin-9, sCD27, PD-L2). Materials and research methods. The objects of study were the patients with precancer (n=13) and cervical cancer (n=49). The control group consisted of 13 gynecologically healthy women. The material of study was cervical epithelium obtained by cervical brush. The research method was flow cytometry. Test parameters: sCD25, 4-1BB, B7.2, TGF-b1, CTLA-4, PD-L1, PD-1, Tim-3, LAG-3, Galectin-9, sCD27, PD-L2. Statistical analysis of the data was carried out using nonparametric statistics using the Mann – Whitney U-test. The results of the study. The levels of sCD25, B7.2, PDL1, Tim-3, sCD27, PD-L2 were increased in the comparison groups relation to the control (p <0.05). The differential criterion for invasive cervical cancer may be an increase in the level of LAG-3 in the cervical epithelium by 43% (p <0.05).The levels of PD-L1, PD-1, sCD27 and PD-L2 were increased opposite the levels LAG-3 and Galectin-9 were decreased in patients with metastatic cervical cancer(p <0.05).Keywords
This publication has 27 references indexed in Scilit:
- PREDICTIVE RESPONSE MARKERS FOR IMMUNE RESPONSE BLOCKSSiberian journal of oncology, 2020
- CTLA-4 rs5742909 polymorphism and cervical cancer riskMedicine, 2020
- Immunotherapy of Patients with Cervical CancerEffective Pharmacotherapy, 2019
- Soluble CD25 as a predictor of hepatocellular carcinoma compared with alpha-fetoproteinClinical and Experimental Hepatology, 2019
- The expression, function, and clinical relevance of B7 family members in cancerCancer Immunology, Immunotherapy, 2012
- Dysregulated Expression of Both the Costimulatory CD28 and Inhibitory CTLA-4 Molecules in PB T Cells of Advanced Cervical Cancer Patients Suggests Systemic Immunosuppression Related to Disease ProgressionPathology and Oncology Research, 2011
- Influence of Membrane CD25 Stability on T Lymphocyte Activity: Implications for ImmunoregulationPLOS ONE, 2009
- The complex role of B7 molecules in tumor immunologyTrends in Molecular Medicine, 2008
- Expression and function of 4‐1BB during CD4 versus CD8 T cell responses in vivoEuropean Journal of Immunology, 2004
- NF‐κB and AP‐1 regulate activation‐dependent CD137 (4‐1BB) expression in T cellsFEBS Letters, 2003